TickerFacts.

Oramed Pharmaceuticals Inc. (ORMP): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

42.42M
Year ended 2025-12-31
+2.8%
3-year compound annual growth
2022-12-31: 39.00M2023-12-31: 40.57M2024-12-31: 40.85M2025-12-31: 42.42M42.42M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3142.42M+3.8%2026-03-26, From 2025-01-01
2024-12-3140.85M+0.7%2026-03-26, From 2024-01-01
2023-12-3140.57M+4.0%2025-03-27, From 2023-01-01
2022-12-3139.00Mn/a2024-03-06, From 2022-01-01